Recent News
View All
Thursday, May 8, 2008
Dana-Farber Cancer Institute Commences Phase 1 Trial With EntreMed’s Selective Kinase Inhibitor
Friday, May 2, 2008
EntreMed Reports First Quarter 2008 Financial Results
Tuesday, April 22, 2008
EntreMed Will Not Seek Shareholder Approval for Reverse Stock Split at Annual Meeting
Wednesday, April 16, 2008
EntreMed Presents MKC-1 and ENMD-1198 Preclinical Data at AACR Annual Meeting
Monday, April 14, 2008
EntreMed’s Kinase Inhibitor, ENMD-2076, Presented During AACR Special Session
Stay Informed
Enter your e-mail address to receive press releases electronically. (Manage your subscription)